Startup profile for AlphaPai: latest funding, latest known valuation, total disclosed funding, investors, status, sources, and why the company is interesting. Part of the Venture Capital Tracker startup directory.

Startup profile · funding coverage

AlphaPai funding, valuation and investors

Hong Kong–based AI investment research assistant and workstation (PaiWork) for professional investors, from Rabyte Technology.

Verified company research · funding, investors and latest developments

Keep track of AlphaPai

Save this profile to your VCT watchlist for a quick return.

View watchlist

Funding, valuation & investors

Answer-first snapshot

Latest funding

Series B

$50M · September 2026

Latest known valuation

Not publicly disclosed

Total disclosed equity funding

$50M

Excludes debt, grants, acquisitions, secondaries, and IPO proceeds.

Current status

private

series b · Hong Kong

Investors in latest funding

Other: China Insurance Investment , GF Xinde Investment Management , Qiming Venture Partners , Ambrum Capital , Next Capital , Trustar Capital , Eastern Bell Capital

Sources: latest funding · en.prnasia.com Last verified: 2026-09-15

Overview

AlphaPai is an AI-native research assistant for institutional investors. PaiWork (launched April 2026) combines financial data, agents, skills, and knowledge bases into one research workstation; the company also launched the iRaB research-agent benchmark and an Open Research Ecosystem partner program. Proceeds fund model/product R&D, multi-asset client expansion, and overseas growth.

Why AlphaPai is interesting

AlphaPai closed a $50M Series B as its third round in a year, pulling in China Insurance Investment and GF Securities’ PE arm alongside Qiming and others — while claiming 120,000+ professional users across 8,000+ institutions. The story is financial AI moving from meeting transcription into the core research workflow, not another generic chatbot wrapper.

Product & use cases

AI investment research assistant and PaiWork workstation that embeds agents, data, and institutional knowledge into professional research workflows for buy-side and sell-side users.

  • Institutional investment research and knowledge management
  • Insurance and multi-asset research / allocation workflows
  • Benchmarking and co-creating research skills across brokerage and data partners

Key facts

  • $50M Series B announced Sep 15, 2026 — third consecutive round in ~1 year (company)
  • Strategic capital: China Insurance Investment; GF Xinde (GF Securities PE)
  • Company: 120,000+ professional users across 8,000+ financial institutions
  • PaiWork AI research workstation launched April 2026; iRaB + ORE ecosystem programs

Funding history (newest first)

Series B

2026-09 $50M
  • China Insurance Investment (participant)
  • GF Xinde Investment Management (participant)
  • Qiming Venture Partners (participant)
  • Ambrum Capital (participant)
  • Next Capital (participant)
  • Trustar Capital (participant)
  • Eastern Bell Capital (participant)

Source: Read source · en.prnasia.com

Market / IPO context

Editorial / static context — not a live quote.

By Venture Capital Tracker

Last updated:

Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.